CD34-DC-based vaccine (University of California San Diego)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD34-DC-based vaccine (University of California San Diego)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionHematopoietic progenitor cell antigen CD34 agonists

TargetsHematopoietic progenitor cell antigen CD34

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California San Diego

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of California San Diego

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A